119 related articles for article (PubMed ID: 19682024)
1. The metabolic syndrome in overweight epileptic patients treated with valproic acid.
Verrotti A; Manco R; Agostinelli S; Coppola G; Chiarelli F
Epilepsia; 2010 Feb; 51(2):268-73. PubMed ID: 19682024
[TBL] [Abstract][Full Text] [Related]
2. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
3. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Pylvänen V; Pakarinen A; Knip M; Isojärvi J
Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
[TBL] [Abstract][Full Text] [Related]
4. The role of valproate in metabolic disturbances in bipolar disorder patients.
Chang HH; Yang YK; Gean PW; Huang HC; Chen PS; Lu RB
J Affect Disord; 2010 Aug; 124(3):319-23. PubMed ID: 20060174
[TBL] [Abstract][Full Text] [Related]
5. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Kim JY; Lee HW
Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
[TBL] [Abstract][Full Text] [Related]
8. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
9. Metabolic alterations during valproic acid treatment: a prospective study.
Abaci A; Saygi M; Yis U; Demir K; Dirik E; Bober E
Pediatr Neurol; 2009 Dec; 41(6):435-9. PubMed ID: 19931165
[TBL] [Abstract][Full Text] [Related]
10. [The prevalence of obesity and metabolic syndrome in paediatric patients with epilepsy treated in monotherapy with valproic acid].
Carmona-Vazquez CR; Ruiz-Garcia M; Pena-Landin DM; Diaz-Garcia L; Greenawalt SR
Rev Neurol; 2015 Sep; 61(5):193-201. PubMed ID: 26308840
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
Grosso S; Mostardini R; Piccini B; Balestri P
Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
[TBL] [Abstract][Full Text] [Related]
12. Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate.
Verrotti A; Greco R; Latini G; De Simone M; Chiarelli F
Neuroendocrinology; 2004 Mar; 79(3):157-62. PubMed ID: 15103229
[TBL] [Abstract][Full Text] [Related]
13. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
[TBL] [Abstract][Full Text] [Related]
14. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents.
Verhulst SL; Schrauwen N; Haentjens D; Rooman RP; Van Gaal L; De Backer WA; Desager KN
J Pediatr; 2007 Jun; 150(6):608-12. PubMed ID: 17517244
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity.
Calcaterra V; Klersy C; Muratori T; Telli S; Caramagna C; Scaglia F; Cisternino M; Larizza D
Clin Endocrinol (Oxf); 2008 Jun; 68(6):868-72. PubMed ID: 17980007
[TBL] [Abstract][Full Text] [Related]
16. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK
Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in overweight and obese Japanese children.
Yoshinaga M; Tanaka S; Shimago A; Sameshima K; Nishi J; Nomura Y; Kawano Y; Hashiguchi J; Ichiki T; Shimizu S
Obes Res; 2005 Jul; 13(7):1135-40. PubMed ID: 16076981
[TBL] [Abstract][Full Text] [Related]
18. Increased oxidative stress in epileptic children treated with valproic acid.
Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
[TBL] [Abstract][Full Text] [Related]
19. Valproic Acid related metabolic syndrome in patients with epilepsy.
Mania M; Kasradze S; Okujava N
Georgian Med News; 2011 May; (194):43-7. PubMed ID: 21685521
[TBL] [Abstract][Full Text] [Related]
20. Lack of valproic acid-associated weight gain in prepubertal children.
Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
